Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Validation of biomarkers of aging

Nature Medicine volume 30, pages 360–372 (2024)Cite this article

Subjects

Abstract

The search for biomarkers that quantify biological aging (particularly ‘omic’-based biomarkers) has intensified in recent years. Such biomarkers could predict aging-related outcomes and could serve as surrogate endpoints for the evaluation of interventions promoting healthy aging and longevity. However, no consensus exists on how biomarkers of aging should be validated before their translation to the clinic. Here, we review current efforts to evaluate the predictive validity of omic biomarkers of aging in population studies, discuss challenges in comparability and generalizability and provide recommendations to facilitate future validation of biomarkers of aging. Finally, we discuss how systematic validation can accelerate clinical translation of biomarkers of aging and their use in gerotherapeutic clinical trials.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Different approaches to cohort study design in the context of biomarkers of aging.
Fig. 2: Validation of biomarkers of aging with different numbers of cohorts or biomarkers.

Similar content being viewed by others

References

  1. Moqri, M. et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186, 3758–3775 (2023).

    CAS  PubMed  Google Scholar 

  2. Moqri, M. et al. PRC2 clock: a universal epigenetic biomarker of aging and rejuvenation. Preprint at bioRxiv https://doi.org/10.1101/2022.06.03.494609 (2022).

  3. Poganik, J. R. et al. Biological age is increased by stress and restored upon recovery. Cell Metab. 35, 807–820 (2023).

    CAS  PubMed  Google Scholar 

  4. Lu, A. T. et al. DNA methylation GrimAge version 2. Aging 14, 9484–9549 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Tanaka, T. et al. Plasma proteomic biomarker signature of age predicts health and life span. eLife 9, e61073 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Balasubramanian, R. et al. Metabolomic profiles associated with all-cause mortality in the Women’s Health Initiative. Int. J. Epidemiol. 49, 289–300 (2020).

    PubMed  Google Scholar 

  7. Sarkar, T. J. et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat. Commun. 11, 1545 (2020).

    ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lee, J. W. et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23, 312–328 (2006).

    CAS  PubMed  Google Scholar 

  9. Wagner, J. A. Overview of biomarkers and surrogate endpoints in drug development. Dis. Markers 18, 41–46 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hunter, D. J. et al. A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Curr. Drug Targets 11, 536–545 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Bortz, J. et al. Biological age estimation using circulating blood biomarkers. Commun. Biol. 6, 1089 (2023).

    PubMed  PubMed Central  Google Scholar 

  12. Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843–1850 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Ahadi, S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat. Med. 26, 83–90 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Alpert, A. et al. A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring. Nat. Med. 25, 487–495 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Rutledge, J., Oh, H. & Wyss-Coray, T. Measuring biological age using omics data. Nat. Rev. Genet. 23, 715–727 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kudryashova, K. S., Burka, K., Kulaga, A. Y., Vorobyeva, N. S. & Kennedy, B. K. Aging biomarkers: from functional tests to multi‐omics approaches. Proteomics 20, 1900408 (2020).

    CAS  Google Scholar 

  17. Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; & Institute of Medicine. Evolution of Translational Omics: Lessons Learned and the Path Forward (eds Micheel, C. M. et al.) (National Academies Press, 2012).

  18. Ying, K. et al. ClockBase: a comprehensive platform for biological age profiling in human and mouse. Preprint at bioRxiv https://doi.org/10.1101/2023.02.28.530532 (2023).

  19. Ying, K. et al. Causality-enriched epigenetic age uncouples damage and adaptation. Nat. Aging https://doi.org/10.1038/s43587-023-00557-0 (2024).

  20. Belsky, D. W. et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 11, e73420 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Bautmans, I. et al. WHO working definition of vitality capacity for healthy longevity monitoring. Lancet Healthy Longev. 3, e789–e796 (2022).

    PubMed  PubMed Central  Google Scholar 

  22. Lara, J. et al. A proposed panel of biomarkers of healthy ageing. BMC Med. 13, 222 (2015).

    PubMed  PubMed Central  Google Scholar 

  23. Crimmins, E. M., Thyagarajan, B., Levine, M. E., Weir, D. R. & Faul, J. Associations of age, sex, race/ethnicity, and education with 13 epigenetic clocks in a nationally representative U.S. sample: the Health and Retirement Study. J. Gerontol. A Biol. Sci. Med. Sci. 76, 1117–1123 (2021).

    PubMed  PubMed Central  Google Scholar 

  24. Faul, J. D. et al. Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality. Proc. Natl Acad. Sci. USA 120, e2215840120 (2023).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Lu, A. T. et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 11, 303–327 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Gadd, D. A. et al. Blood protein levels predict leading incident diseases and mortality in UK Biobank. Preprint at medRxiv https://doi.org/10.1101/2023.05.01.23288879 (2023).

  27. Tian, Y. E. et al. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat. Med. 29, 1221–1231 (2023).

    CAS  PubMed  Google Scholar 

  28. Buergel, T. et al. Metabolomic profiles predict individual multidisease outcomes. Nat. Med. 28, 2309–2320 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Raghavachari, N., Wilmot, B. & Dutta, C. Optimizing translational research for exceptional health and life span: a systematic narrative of studies to identify translatable therapeutic target(s) for exceptional health span in humans. J. Gerontol. A Biol. Sci. Med. Sci. 77, 2272–2280 (2022).

    PubMed  PubMed Central  Google Scholar 

  30. Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518 (2023).

    ADS  CAS  PubMed  PubMed Central  Google Scholar 

  31. Nagai, A. et al. Overview of the BioBank Japan Project: study design and profile. J. Epidemiol. 27, S2–S8 (2017).

    PubMed  PubMed Central  Google Scholar 

  32. Boutin, N. T. et al. The evolution of a large biobank at Mass General Brigham. J. Pers. Med. 12, 1323 (2022).

    PubMed  PubMed Central  Google Scholar 

  33. Huan, T. et al. Integrative analysis of clinical and epigenetic biomarkers of mortality. Aging Cell 21, e13608 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Eiriksdottir, T. et al. Predicting the probability of death using proteomics. Commun. Biol. 4, 758 (2021).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Deelen, J. et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat. Commun. 10, 3346 (2019).

    ADS  PubMed  PubMed Central  Google Scholar 

  36. Kuiper, L. M. et al. Epigenetic and metabolomic biomarkers for biological age: a comparative analysis of mortality and frailty risk. J. Gerontol. A Biol. Sci. Med. Sci. 78, 1753–1762 (2023).

    PubMed  PubMed Central  Google Scholar 

  37. Wang, C. et al. DNA methylation-based biomarkers of age acceleration and all-cause death, myocardial infarction, stroke, and cancer in two cohorts: the NAS, and KORA F4. eBioMedicine 63, 103151 (2021).

    CAS  PubMed  Google Scholar 

  38. Evans, M. K. et al. Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS): overcoming barriers to implementing a longitudinal, epidemiologic, urban study of health, race, and socioeconomic status. Ethn. Dis. 20, 267–275 (2010).

    PubMed  Google Scholar 

  39. Olivia, S. et al. Comparison of DNA methylation measured by Illumina 450K and EPIC BeadChips in blood of newborns and 14-year-old children. Epigenetics 13, 655–664 (2018).

    Google Scholar 

  40. Koistinen, V. et al. Towards a Rosetta stone for metabolomics: recommendations to overcome inconsistent metabolite nomenclature. Nat. Metab. 5, 351–354 (2023).

    CAS  PubMed  Google Scholar 

  41. Fahy, E. & Subramaniam, S. RefMet: a reference nomenclature for metabolomics. Nat. Methods 17, 1173–1174 (2020).

    CAS  PubMed  Google Scholar 

  42. Yu, B. et al. The Consortium of Metabolomics Studies (COMETS): metabolomics in 47 prospective cohort studies. Am. J. Epidemiol. 188, 991–1012 (2019).

    PubMed  PubMed Central  Google Scholar 

  43. Psaty, B. M. et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. 2, 73–80 (2009).

    PubMed  PubMed Central  Google Scholar 

  44. Keane, T. & Glass, L. CINECA: Common Infrastructure for National Cohorts in Europe, Canada, and Africa — Kick Off Report. Zenodo https://doi.org/10.5281/zenodo.3908145 (2019).

  45. Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290–299 (2021).

    ADS  CAS  PubMed  PubMed Central  Google Scholar 

  46. Linsen, L. et al. Raising to the challenge: building a federated biobank to accelerate translational research—the University Biobank Limburg. Front. Med. 6, 224 (2019).

    Google Scholar 

  47. Kaye, J. et al. Access governance for biobanks: the case of the BioSHaRE-EU cohorts. Biopreserv. Biobank. 14, 201–206 (2016).

    PubMed  PubMed Central  Google Scholar 

  48. Cummings, S. R. & Kritchevsky, S. B. Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age. GeroScience 44, 2925–2931 (2022).

    PubMed  PubMed Central  Google Scholar 

  49. Kaeberlein, M. How healthy is the healthspan concept? GeroScience 40, 361–364 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Okada, D., Cheng, J. H., Zheng, C., Kumaki, T. & Yamada, R. Data-driven identification and classification of nonlinear aging patterns reveals the landscape of associations between DNA methylation and aging. Hum. Genomics 17, 8 (2023).

    CAS  Google Scholar 

  51. Higgins-Chen, A. T. et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nat. Aging 2, 644–661 (2022).

    PubMed  PubMed Central  Google Scholar 

  52. Tomusiak, A. et al. Development of a novel epigenetic clock resistant to changes in immune cell composition. Preprint at bioRxiv https://doi.org/10.1101/2023.03.01.530561 (2023).

  53. Fang, F. et al. Evaluation of pediatric epigenetic clocks across multiple tissues. Clin. Epigenetics 15, 142 (2023).

    Google Scholar 

  54. Johnson, N. D. et al. Non-linear patterns in age-related DNA methylation may reflect CD4+ T cell differentiation. Epigenetics 12, 492–503 (2017).

    PubMed  PubMed Central  Google Scholar 

  55. Zhou, W. et al. SeSAMe: Reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, 20 (2018).

    Google Scholar 

  56. Emmanuel, T. et al. A survey on missing data in machine learning. J. Big Data 8, 140 (2021).

    Google Scholar 

  57. Li, P., Stuart, E. A. & Allison, D. B. Multiple imputation: a flexible tool for handling missing data. JAMA 314, 1966–1967 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Paul, Y. et al. Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies. Epigenetics 8, 1141–1152 (2013).

  59. Bizzarri, D., Reinders, M. J. T., Beekman, M., Slagboom, P. E. & van den Akker, E. B. MiMIR: R-shiny application to infer risk factors and endpoints from Nightingale Health’s 1H-NMR metabolomics data. Bioinformatics 38, 3847–3849 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Kwon, D. & Belsky, D. W. A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge. GeroScience 43, 2795–2808 (2021).

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Ying, K. et al. Biolearn, an open-source library for biomarkers of aging. Preprint at bioRxiv https://doi.org/10.1101/2023.12.02.569722 (2023).

  62. Thrush, K. L., Higgins-Chen, A. T., Liu, Z. & Levine, M. E. R methylCIPHER: a methylation clock investigational package for hypothesis-driven evaluation & research. Preprint at bioRxiv https://doi.org/10.1101/2022.07.13.499978 (2022).

  63. Pun, F. W. et al. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging 14, 2475–2506 (2022).

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Manning, A. K. et al. NHLBI BioData Catalyst and the future of cloud computing. Genet. Epidemiol. 45, 774–775 (2021).

  65. Li, T., Sahu, A. K., Talwalkar, A. & Smith, V. Federated learning: challenges, methods, and future directions. IEEE Signal Process. Mag. 37, 50–60 (2020).

    CAS  Google Scholar 

  66. Fortier, I. et al. Maelstrom Research guidelines for rigorous retrospective data harmonization. Int. J. Epidemiol. 46, 103–105 (2017).

    PubMed  Google Scholar 

  67. Wilkinson, M. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).

  68. Tang, M. X. et al. The APOE-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279, 751–755 (1998).

    CAS  PubMed  Google Scholar 

  69. Benjamin, C. T. et al. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager–horticulturalists with a high parasite burden. FASEB J. 31, 1251–1767 (2017).

  70. Privé, F. et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am. J. Hum. Genet. 109, 12–23 (2022).

    PubMed  PubMed Central  Google Scholar 

  71. Graf, G. H. et al. Testing Black–white disparities in biological aging among older adults in the United States: analysis of DNA-methylation and blood-chemistry methods. Am. J. Epidemiol. 191, 613–625 (2022).

    PubMed  Google Scholar 

  72. Liu, Z. et al. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 15, e1002718 (2018).

    PubMed  PubMed Central  Google Scholar 

  73. Vandenbroucke, J. P. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 4, e297 (2007).

    PubMed  PubMed Central  Google Scholar 

  74. Rodés, B., Cadiñanos, J., Esteban-Cantos, A., Rodríguez-Centeno, J. & Arribas, J. R. Ageing with HIV: challenges and biomarkers. eBioMedicine 77, 103896 (2022).

    PubMed  PubMed Central  Google Scholar 

  75. Cohen, A. A. et al. Detection of a novel, integrative aging process suggests complex physiological integration. PLoS ONE 10, e0116489 (2015).

    PubMed  PubMed Central  Google Scholar 

  76. Ferrucci, L. & Kohanski, R. Better care for older patients with complex multimorbidity and frailty: a call to action. Lancet Healthy Longev. 3, e581–e583 (2022).

    PubMed  Google Scholar 

  77. Baker, G. T. & Sprott, R. L. Biomarkers of aging. Exp. Gerontol. 23, 223–239 (1988).

    PubMed  Google Scholar 

  78. Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573–591 (2018).

    PubMed  PubMed Central  Google Scholar 

  79. Sebastiani, P. et al. Biomarker signatures of aging. Aging Cell 16, 329–338 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Mamoshina, P. et al. Population specific biomarkers of human aging: a big data study using South Korean, Canadian, and Eastern European patient populations. J. Gerontol. A Biol. Sci. Med. Sci. 73, 1482–1490 (2018).

    PubMed  PubMed Central  Google Scholar 

  81. Zhang, Y. et al. DNA methylation signatures in peripheral blood strongly predict all-cause mortality. Nat. Commun. 8, 14617 (2017).

    ADS  CAS  PubMed  PubMed Central  Google Scholar 

  82. Bernabeu, E. et al. Refining epigenetic prediction of chronological and biological age. Genome Med. 15, 12 (2023).

    CAS  PubMed  PubMed Central  Google Scholar 

  83. van den Akker, E. B. et al. Metabolic age based on the BBMRI-NL 1H-NMR metabolomics repository as biomarker of age-related disease. Circ. Genom. Precis. Med. 13, 541–547 (2020).

    PubMed  Google Scholar 

  84. Li, X. et al. Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up. eLife 9, e51507 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Hillary, R. F. et al. Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden. Clin. Epigenet. 12, 115 (2020).

    Google Scholar 

  86. McCrory, C. et al. GrimAge outperforms other epigenetic clocks in the prediction of age-related clinical phenotypes and all-cause mortality. J. Gerontol. A Biol. Sci. Med. Sci. 76, 741–749 (2021).

    PubMed  Google Scholar 

  87. Tiina, F. et al. Does the epigenetic clock GrimAge predict mortality independent of genetic influences: an 18 year follow-up study in older female twin pairs. Clin. Epigenetics 13, 128 (2021).

    CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, and grants from the National Institute on Aging and Hevolution Foundation. D.P.K. was supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041398). We are very grateful to D.M. Wilson III for many suggestions during the writing of this paper. We express our gratitude to all members of the Biomarkers of Aging Consortium Roadmap Group (https://www.agingconsortium.org/) for their fruitful discussions that helped to define the scope and direction of this work. The list of authors reflects Roadmap Group members who directly contributed to or refined the manuscript.

Author information

Author notes

  1. These authors contributed equally: Mahdi Moqri, Chiara Herzog, Jesse R. Poganik.

Authors and Affiliations

  1. Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Mahdi Moqri, Jesse R. Poganik, Kejun Ying & Vadim N. Gladyshev

  2. Department of Genetics, School of Medicine, Stanford University, Stanford, CA, USA

    Mahdi Moqri & Michael P. Snyder

  3. Department of Obstetrics and Gynecology, School of Medicine, Stanford University, Stanford, CA, USA

    Mahdi Moqri & Vittorio Sebastiano

  4. European Translational Oncology Prevention and Screening Institute, Universität Innsbruck, Innsbruck, Austria

    Chiara Herzog & Martin Widschwendter

  5. T.H. Chan School of Public Health, Harvard University, Boston, MA, USA

    Kejun Ying

  6. Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA

    Jamie N. Justice

  7. Department of Epidemiology, Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, NY, USA

    Daniel W. Belsky

  8. Department of Psychiatry, Yale University, New Haven, CT, USA

    Albert T. Higgins-Chen

  9. Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA, USA

    Brian H. Chen

  10. Department of Environmental Health Sciences, Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, NY, USA

    Alan A. Cohen

  11. Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany

    Georg Fuellen

  12. School of Medicine, University College Dublin, Dublin, Ireland

    Georg Fuellen

  13. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    Sara Hägg

  14. Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK

    Riccardo E. Marioni

  15. Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, London, UK

    Martin Widschwendter

  16. Department of Women’s and Children’s Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden

    Martin Widschwendter

  17. BioAge Labs, Richmond, CA, USA

    Kristen Fortney

  18. Gero PTE, Singapore, Singapore

    Peter O. Fedichev

  19. Insilico Medicine Hong Kong, Hong Kong SAR, China

    Alex Zhavoronkov

  20. Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY, USA

    Nir Barzilai

  21. Department of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Jessica Lasky-Su

  22. Musculoskeletal Research Center, Hinda and Arthur Marcus Institute for Aging Research and Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

    Douglas P. Kiel

  23. Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Brian K. Kennedy

  24. Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Healthy Longevity, @AgeSingapore, National University Health System, Singapore, Singapore

    Brian K. Kennedy & Andrea B. Maier

  25. San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA, USA

    Steven Cummings

  26. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA

    Steven Cummings

  27. Section of Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands

    P. Eline Slagboom

  28. Buck Institute for Research on Aging, Novato, CA, USA

    Eric Verdin

  29. Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

    Andrea B. Maier

  30. Altos Labs, San Diego, CA, USA

    Steve Horvath

  31. National Institute on Aging, Baltimore, MD, USA

    Luigi Ferrucci

Authors
  1. Mahdi Moqri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Herzog
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesse R. Poganik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kejun Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jamie N. Justice
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel W. Belsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Albert T. Higgins-Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Brian H. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alan A. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Georg Fuellen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sara Hägg
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Riccardo E. Marioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Martin Widschwendter
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Kristen Fortney
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Peter O. Fedichev
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Alex Zhavoronkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Nir Barzilai
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jessica Lasky-Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Douglas P. Kiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Brian K. Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Steven Cummings
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. P. Eline Slagboom
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Eric Verdin
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Andrea B. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Vittorio Sebastiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Michael P. Snyder
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Vadim N. Gladyshev
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Steve Horvath
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Luigi Ferrucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Vadim N. Gladyshev, Steve Horvath or Luigi Ferrucci.

Ethics declarations

Competing interests

M.M., V.S., M.P.S. and V.N.G. have filed a patent on measuring cellular aging. C.H. is also affiliated with the Institute for Biomedical Aging Research, Universität Innsbruck, Austria and is an honorary research fellow at the Department of Women’s Cancer, EGA Institute for Women’s Health, University College London. C.H. is a shareholder of Sola Diagnostics and is named as an inventor on a patent on an epigenetic clock indicative of breast cancer risk. J.N.J. is also affiliated with the Sticht Center for Healthy Aging and Alzheimer’s Prevention, Wake Forest University School of Medicine and the XPRIZE Foundation. J.N.J. serves on the advisory board for the American Federation for Aging Research’s Finding Aging Biomarkers by Searching Existing Trials Initiative and the editorial board of the Journals of Gerontology Series A Biological Sciences, eLife and Experimental Gerontology. D.W.B. is also affiliated with the Child Brain Development Network, Canadian Institute for Advanced Research and SocioMed Research Nucleus and Universidad Mayor. D.W.B. is an inventor of DunedinPACE, a Duke University and University of Otago invention licensed to TruDiagnostic. A.T.H.-C. is an inventor of epigenetic clocks that are the subject of a provisional patent and have been licensed to TruDiagnostic. A.T.H.-C. has also received consulting fees from TruDiagnostic and FOXO Biosciences. B.H.C. owns stock in Illumina, the manufacturer of the DNA methylation arrays used in epigenetic biomarkers of aging, and is listed as a co-inventor on filed patents on commercial applications of epigenetic prediction models. A.A.C. is a founder, president and majority shareholder at Oken Health. R.E.M. has received a speaker fee from Illumina and is an advisor to the Epigenetic Clock Development Foundation and Optima Partners. M.W. is also affiliated with the Institute for Biomedical Aging Research, Universität Innsbruck. M.W. is a shareholder of Sola Diagnostics and is named as an inventor on a patent on an epigenetic clock indicative of breast cancer risk. K.F. is the CEO of BioAge Labs. P.O.F. is an employee and stakeholder of Gero. A.Z. is the founder and the CEO of Insilico Medicine, a clinical-stage generative AI and robotics biotechnology company specializing in aging research. N.B. is the scientific director of the American Federation for Aging Research, is on the board of the executive committee of the Longevity Biotech Association and is advisor on the board of the Academy for Health and Lifespan Research. D.P.K. has received a grant from Solarea Bio and royalties from Wolters Kluwer. D.P.K. sits on the scientific advisory boards of Solarea Bio, Pfizer, Radius Health and Reneo and has participated in the data safety monitoring board for the AgNovos Healthcare treatment trial. E.V. is a scientific cofounder of Napa Therapeutics and BHB Therapeutics, serves on the scientific advisory board of Seneque and is a named co-inventor on a patent relating to an epigenetic clock robust to cell composition changes. A.B.M. declares herself chief medical officer of NU and co-founder of Chi Longevity. V.S. is a cofounder, SAB chair and head of research of Turn Biotechnologies. M.P.S. is a cofounder and scientific advisor of Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, Protos, RTHM, iollo, Marble Therapeutics, Crosshair Therapeutics and Mirvie. He is a scientific advisor of Jupiter, Neuvivo, Swaza and Mitrix. S. Horvath is a founder of the nonprofit Epigenetic Clock Development Foundation that licenses patents surrounding epigenetic clocks. The Regents of the University of California is the sole owner of a patent application directed at GrimAge and other epigenetic clocks for which S. Horvath is a named inventor.

Peer review

Peer review information

Nature Medicine thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Karen O’Leary, in collaboration with the Nature Medicine team.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Note and Tables 1–3

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moqri, M., Herzog, C., Poganik, J.R. et al. Validation of biomarkers of aging. Nat Med 30, 360–372 (2024). https://doi.org/10.1038/s41591-023-02784-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02784-9

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research